Philips NV

PHIA

NL0000009538

Advanced Medical Equipment & Technology

Market Closed - Euronext Amsterdam Other stock markets 11:35:17 2024-05-14 EDT			5-day change	1st Jan Change
25.09 ^EUR	-0.59%		+1.13%	+18.99%

05-09	European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading	MT
05-07	PHILIPS : Jefferies remains negative, but raises its target	CF

PHILIPS NV : JP Morgan reaffirms its Sell rating

April 29, 2024 at 03:17 am

The analyst from JP Morgan, David Adlington, maintains his advice to sell. The target price is still set at EUR 19.50.

Latest news about Philips NV

European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading	05-09	MT
PHILIPS : Jefferies remains negative, but raises its target	05-07	CF
PHILIPS NV : Jefferies remains a Sell rating	05-07	ZD
Elekta to Buy Philips Healthcare's Treatment Planning Patent Portfolio	05-03	MT
PHILIPS NV : DZ Bank reiterates its Neutral rating	05-02	ZD
Moody's Affirms Royal Philips' Rating, Upgrades Outlook on Enhanced Performance	05-02	MT
UBS Upgrades Koninklijke Philips to Neutral From Sell	04-30	MT
PHILIPS : Deutsche Bank upgrades recommendation to 'hold	04-30	CF
PHILIPS NV : Barclays reiterates its Buy rating	04-30	ZD
PHILIPS NV : Deutsche Bank reaffirms its Neutral rating	04-30	ZD
PHILIPS : UBS raises its recommendation	04-30	CF
PHILIPS NV : Goldman Sachs maintains a Buy rating	04-30	ZD
PHILIPS NV : Deutsche Bank withdraws its Sell rating	04-30	ZD
PHILIPS NV : UBS from Sell to Neutral	04-30	ZD
PHILIPS NV : JP Morgan from Sell to Neutral	04-30	ZD
ROYAL PHILIPS : The Dutch giant now poised for much better times	04-29
PHILIPS NV : Barclays remains its Buy rating	04-29	ZD
ROYAL PHILIPS : Litigation uncertainty no longer an overhang; Q1 profitability beat	04-29
Tech Rally Subsides as US Equity Futures Waver Pre-Bell	04-29	MT
Top Premarket Gainers	04-29	MT
PHILIPS NV : UBS reiterates its Sell rating	04-29	ZD
Philips Settles US Sleep Therapy Litigation for $1.1 Billion; Reaffirms 2024 Comparable Sales Outlook	04-29	MT
European shares hit two-week high; inflation data, Fed meeting in focus	04-29	RE
PHILIPS NV : Receives a Buy rating from Goldman Sachs	04-29	ZD
Transcript : Koninklijke Philips N.V., Q1 2024 Earnings Call, Apr 29, 2024	04-29

Koninklijke Philips N.V. is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. The group leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Koninklijke Philips N.V. is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-05-21 - Deutsche Bank dbAccess European Champions Conference

Related indices

STOXX EUROPE 600 (EUR) , AEX

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

ROYAL PHILIPS : The Dutch giant now poised for much better times

April 29, 2024 at 01:48 pm

Philips NV : The sleep apnea case makes a brutal comeback

October 06, 2023 at 05:20 am

Product recalls, renewed growth, investment in AI. Roy Jakobs, Philips CEO

September 29, 2023 at 10:33 am

More Strategies

Ratings for Philips NV

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

25.09 EUR

Average target price

25.87 EUR

Spread / Average Target

+3.11%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
PHILIPS NV	+18.99%	24.63B
THERMO FISHER SCIENTIFIC	+12.06%	225B
DANAHER CORPORATION	+12.07%	186B
INTUITIVE SURGICAL, INC.	+13.88%	135B
BOSTON SCIENTIFIC CORPORATION	+27.12%	107B
SIEMENS HEALTHINEERS AG	+0.91%	63.56B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+6.74%	51.32B
EDWARDS LIFESCIENCES CORPORATION	+13.39%	51.04B
AGILENT TECHNOLOGIES, INC.	+8.81%	43.3B
GE HEALTHCARE TECHNOLOGIES INC.	+4.14%	36.99B

Other Advanced Medical Equipment & Technology

Philips NV

Equities

PHIA

NL0000009538

Advanced Medical Equipment & Technology

PHILIPS NV : JP Morgan reaffirms its Sell rating

Latest news about Philips NV

Chart Philips NV

Company Profile

Income Statement Evolution

Analysis / Opinion

Ratings for Philips NV

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Advanced Medical Equipment & Technology